Stay updated with breaking news from Rckt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) had its price objective raised by research analysts at Chardan Capital from $60.00 to $62.00 in a note issued to investors on Thursday, The Fly reports. A number of other analysts have also recently weighed in on the stock. Zacks Investment Research cut shares of Rocket Pharmaceuticals from a […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) had its target price upped by analysts at SVB Leerink from $64.00 to $66.00 in a research note issued to investors on Friday, Stock Target Advisor reports. The firm presently has an “outperform” rating on the biotechnology company’s stock. RCKT has been the subject of a number of other […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Rocket Pharmaceuticals, Inc. is an emerging, clinical-stage biotechnology company. It focused on developing first-in-class gene therapy treatment options for rare, undertreated […]